Biogen ends Alzheimer’s trials; CVS starts selling CBD products; 70% say government spends too little on healthcare.
Novo submits diabetes pill for ‘priority review’; Top FDA compounding staffer to exit; Roman launches women’s product
Experts discussed artificial intelligence and machine learning at the ePharma Impact conference in New York on Wednesday.
Marketing and regulatory experts talked about how pharma can keep up with other industries and stay within the lines of the federal regulations.
The acquisition represents the U.K. health network’s third in the U.S.
Sanofi begins CEO succession plan; FDA places partial hold on Venclexta cancer trials; One-third of uninsured patients reduce costs by not taking medicine as prescribed.
She has worked at the agency for five years, most recently as chief strategy officer.
Redefining creativity, giving agency leaders more financial freedom and making client services more consultant-like are on the WPP chief’s agenda.
Apple Watch warns 0.5% of users; Amarin’s Vascepa also helps prevent second and third heart attacks; Ohio sues OptumRx for overcharging for drugs.
Amag is offering a chatbot to help women who want to learn about its product for painful sex do so privately.